33 results
8-K
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
, the Company was joined in filing a Chapter 11 involuntary bankruptcy lawsuit in the United States Bankruptcy Court in the District of Colorado (Denver
8-K
EX-10.1
swu6tba
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
p4gxdv8g9
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
S-8
dbdd rnfd26
15 Oct 18
Registration of securities for employees
9:22am
S-1
z7l f9k2vgq
14 Oct 16
IPO registration
12:00am
DRS/A
ee7uby 0eckmi8
14 Oct 16
Draft registration statement (amended)
12:00am